Pioglitazone for the treatment of Alzheimer's disease

Daniela Galimberti, PhD from the University of Milan, Milan, Italy discusses a study on pioglitazone for the treatment of Alzheimer's disease at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands. The drug acts on a receptor involved in inflammatory mechanisms and the rationale is to interfere with inflammation in Alzheimer’s disease.

• #education
• #speaker_daniela_galimberti
• #subject_dementia
• #event_ean_2017
• #medicines_pioglitazone
• #field_biology
• #target_inflammation
• #inflammatory_mechanisms
• #format_interview
• #subject_alzheimers_disease